Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
|
|
Corium International, Inc. (CORI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/02/2019 |
GN
| Corium Appoints Perry Sternberg as Chief Executive Officer |
| 12/17/2018 |
GN
| Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025 |
| 11/07/2018 |
GN
| Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Corium, Hamilton, and Penn Virginia on Behalf of Stockholders and Encourages Investors to Contact the Firm |
| 10/23/2018 |
GN
| MERGER ALERT – CORI, ESL and IMPV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 10/17/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Gogo, Jagged Peak Energy, Everbridge, Roku, Corium International, and Ionis Pharmaceuticals — New Research Emphasizes Economic Growth |
| 10/12/2018 |
GN
| Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Corium International, Inc. (CORI) on Behalf of Stockholders and Encourages CORI Investors to the Firm |
| 10/12/2018 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Corium International, Inc. to Gurnet Point Capital is Fair to Shareholders |
| 10/11/2018 |
GN
| Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares |
| 09/24/2018 |
GN
| Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference |
| 08/29/2018 |
GN
| Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference |
| 08/22/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Ciena, Corium International, Regulus Therapeutics, Marten Transport, Pandora Media, and Heartland Express — New Research Emphasizes Economic Growth |
| 08/09/2018 |
GN
| Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights |
| 07/25/2018 |
GN
| Corium Presents Additional Positive Clinical Results at Alzheimer's Association International Conference® 2018 |
| 07/11/2018 |
GN
| Corium Announces Issuance of Additional U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer's Disease |
| 06/13/2018 |
GN
| Corium Announces Issuance of Key U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer's Disease |
| 05/24/2018 |
GN
| Corium to Present at the Jefferies 2018 Global Healthcare Conference |
| 03/19/2018 |
GN
| Corium to Present at the 17th Annual Needham Healthcare Conference |
| 03/01/2018 |
GN
| Corium Prices Offering of $100 Million of 5% Convertible Senior Notes |
| 02/28/2018 |
GN
| Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study |
| 02/08/2018 |
GN
| Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights |
| 02/02/2018 |
GN
| New Research: Key Drivers of Growth for Dova Pharmaceuticals, Park Electrochemical, Corium International, Sirius XM, Home Depot, and Walgreens Boots Alliance — Factors of Influence, Major Initiatives and Sustained Production |
| 02/01/2018 |
GN
| Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018 |
| 12/12/2017 |
GN
| Corium to Join NASDAQ Biotechnology Index |
| 11/16/2017 |
GN
| Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights |
| 08/03/2017 |
GN
| Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 |
| 07/18/2017 |
GN
| Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 |
| 07/06/2017 |
GN
| Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017 |
| 06/26/2017 |
GN
| Corium Joins Russell 3000® Index |
| 05/31/2017 |
GN
| Corium Announces Closing of Follow-On Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares |
| 05/25/2017 |
GN
| Corium Prices Follow-On Offering of Common Stock |
| 05/24/2017 |
GN
| Corium Announces Proposed Public Offering of Common Stock |
| 05/11/2017 |
GN
| Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study |
| 05/11/2017 |
GN
| Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights |
| 05/09/2017 |
GN
| Corium to Report Preliminary Results from Corplex Donepezil Pilot Study and Second Quarter Fiscal 2017 Financial Results Before Market Open on Thursday, May 11, 2017 |
|
|
|